Early recipient of transcatheter aortic valve receives Courageous Patient Award

Lillian Feldshuh, of Scarsdale, NY, an early recipient of a transcatheter aortic valve in 2006, received the Courageous Patient Award yesterday at the Transcatheter Cardiovascular Therapeutics (TCT 2010) scientific symposium in Washington, DC. The procedure was a success and Feldshuh, who will turn 100 years in just 7 months, remains in good health.

In 2006, Lillian Feldshuh suffered from aortic stenosis, a severely life-threatening heart condition. Even though she had been told there were no options, the team at NewYork-Presbyterian Hospital/Columbia University Medical Center, led by Dr. Martin B. Leon, performed percutaneous aortic valve replacement on the then 95-year-old woman. On September 23rd, that team presented her with the award.

Mrs. Feldshuh was accompanied to Washington by her children, Broadway actress Tovah Feldshuh and playwright and physician David Feldshuh. She delivered her acceptance remarks to an audience of over 3,000 physicians.

"In June 2006, I was given the choice to die or take the chance to live. Naturally, I chose to take the chance to live. Maybe I'm a pioneer, I don't know. But I accept this award with gratitude and wonder. Who could have predicted in 1911 that in my hundredth year I would be receiving an award from the finest doctors in the world? I've had a blessed life. To reach this time and these years and be with you today, life is wonderful. I thank you from the bottom of my heart," Feldshuh said.

Still in an experimental phase, transcatheter valves may become a treatment option for people with a life threatening condition known as aortic stenosis, according to new data presented this week at TCT, and in an article in the New England Journal of Medicine.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study: 40% of newly diagnosed heart failure patients also have atrial fibrillation